2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Neoplasms
2
Endometrial Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma, Hepatocellular
2
Adenocarcinoma of Lung
2
Uterine Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumor
1
Radiomics
1
Prostatic Neoplasms
1
Pituitary Diseases
1
Pancreatic Neoplasms
1
Pancreatic Ductal Adenocarcinoma
1
Neuroendocrine Tumors
1
Lung Neoplasms
1
Lung Diseases
1
Liver Cirrhosis
1
Hepatitis B
1
Head and Neck Neoplasms
1
Disease Progression
1
Carcinoma, Squamous Cell
1
Carcinoma, Renal Cell
1
Carcinoma, Lobular
1
Carcinoma, Ductal, Breast
1
Breast Neoplasms
1
Bone Neoplasms
1
Interventions
Carboplatin
345
Cisplatin
240
Paclitaxel
208
Radiotherapy
206
Pemetrexed
190
Docetaxel
170
Gemcitabine
158
pembrolizumab
146
Erlotinib Hydrochloride
111
Magnetic Resonance Spectroscopy
101
Etoposide
98
Bevacizumab
96
Specimen Handling
84
Nivolumab
77
durvalumab
73
Radiosurgery
73
Blood Specimen Collection
65
Drug Therapy
61
osimertinib
56
Vinorelbine
54
Gefitinib
50
Surveys and Questionnaires
48
atezolizumab
44
Biopsy
43
Irinotecan
42
Radiation
41
Topotecan
39
Standard of Care
38
Cyclophosphamide
38
Surgical Procedures, Operative
35
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lung Neoplasms
×
Radiomics
×
Clear all
NCT03872362
2019-03-13
RMBPN
Maastricht University
Completed
800 enrolled